DRKS00021042已完成未知
Efficient healthcare for children with cancer using telemedicine in Schleswig-Holstein - KULT-SH
Dekanat der Medizinischen Fakultät, Christian-Albrechts-Universität zu Kiel0 个研究点目标入组 55 人开始时间: 2020年4月3日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 55
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized controlled study
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 1 Years 至 25 Years（—）
- 性别
- All
入选标准
- •Newly diagnosed malignant disease or malignant disease under Treatment OR condition after allogeneic hematopoietic stem cell Transplantation under drug-immunosuppressive therapy.
- •AND age = 1 year to 25 years.
- •AND therapy Duration from inclusion = 6 months.
- •AND anticipated high-frequency contact phases ( = 2 doctor-patient contacts per week during therapy).
- •AND internet access at home.
排除标准
- •Inclusion criteria not available AND/OR poor language skills which do not allow for a video-/audio conference
研究者
相似试验
终止
不适用
Healthy Eating Learning Program (HELP) Study for Children Recovering from Cancer.Feeding DifficultiesChildren recovering from cancerCancer - Any cancerDiet and Nutrition - Other diet and nutrition disordersACTRN12611000732987Children's Nutrition Research Centre, University of Queensland96
已完成
不适用
Pilot testing of a decision aid for nutrition support in paediatric oncology.Malnutrition in paediatric oncologyDiet and Nutrition - Other diet and nutrition disordersCancer - Any cancerACTRN12615001082594Behavioural Sciences Unit, Sydney Children's Hospital40
已完成
Unknown
To evaluate the outcomes of paediatric cancer patients admitted to the intensive care unitCTRI/2018/01/011576ot applicable200
尚未招募
不适用
Comprehensive detection of childhood cancer predisposing genes using exome sequencing: The next step towards personalized treatment and cancer prevention.kanker op de kinderleeftijdchildhood cancerpediatric tumors1002766410027655NL-OMON37736niversitair Medisch Centrum Sint Radboud180
招募中
不适用
Preventing adverse events during paediatric cancer treatment: A multi-site hybrid randomised controlled trial of catheter lock solutions (The CLOCK trial)Paediatric CancerCentral vascular access device (CVAD) related adverse eventsCancer - Any cancerACTRN12622000499785niversity of Queensland720